Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Total Current Liabilities (2016 - 2025)

Bone Biologics has reported Total Current Liabilities over the past 3 years, most recently at $961795.0 for Q4 2017.

  • Quarterly Total Current Liabilities fell 35.96% to $961795.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $961795.0 through Dec 2017, down 35.96% year-over-year, with the annual reading at $961795.0 for FY2017, 35.96% down from the prior year.
  • Total Current Liabilities was $961795.0 for Q4 2017 at Bone Biologics, down from $3.8 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $3.8 million in Q3 2017 and troughed at $335622.0 in Q3 2016.
  • The 3-year median for Total Current Liabilities is $1.5 million (2016), against an average of $1.6 million.
  • The largest YoY upside for Total Current Liabilities was 1038.07% in 2017 against a maximum downside of 35.96% in 2017.
  • A 3-year view of Total Current Liabilities shows it stood at $2.1 million in 2015, then fell by 29.99% to $1.5 million in 2016, then tumbled by 35.96% to $961795.0 in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Total Current Liabilities are $961795.0 (Q4 2017), $3.8 million (Q3 2017), and $2.7 million (Q2 2017).